In a significant study, scientists from the renowned Institut Pasteur, in collaboration with the Alternative Energies and Atomic Energy Commission (CEA) in France, have uncovered a startling revelation that the notorious SARS-CoV-2 virus can persist in the lungs of certain individuals for a staggering 18 months after infection. This discovery sheds light on a previously unknown aspect of the virus’s behavior, establishing a secretive stronghold in the body referred to as “viral reservoirs.”

Unlike the typical trajectory where the SARS-CoV-2 virus becomes undetectable in the upper respiratory tract one to two weeks after contracting COVID, this research, conducted on lung cells in an animal model and published in the prestigious journal Nature Immunology, exposes the virus’s ability to outsmart the body’s initial defense mechanism—the innate immune system.

The phenomenon of prolonged viral persistence isn’t unique to SARS-CoV-2. The researchers draw striking parallels with other notorious viruses, including HIV, which cunningly lies dormant in specific immune cells, capable of reactivating unpredictably. This suggests an alarming similarity in the SARS-CoV-2 virus’s capacity, responsible for the global havoc of COVID-19, to establish an enduring residency within the human body.

Covid remains a perplexing challenge for experts due to its diverse impact on the health of infected individuals, and ongoing revelations from experts continue to emerge in public forums. The scientific community is still grappling with the lack of data in comprehending what is commonly referred to as long covid.

READ MORE: COVID vax not linked to unexplained deaths in youth 

An editorial in Nature Immunology declares that the enigma of post-infection long COVID remains veiled in mystery. It emphasizes the crucial need to distinguish between lingering symptoms of the acute disease, which typically subside around six months post-infection, and the onset of new symptoms. Surprisingly, these new symptoms can persist for an astonishing 24 months in patients who initially experienced a milder form of the disease during the acute phase.

In another study quoted in the editorial “Spaan and colleagues” delve into the genetic and immunological foundations of inherent resistance to SARS-CoV-2, providing a fascinating glimpse into the complexities of our body’s defense against this relentless adversary.

With a scarcity of studies in this vital field, experts are compelled to rely on observations from patients with severe acute infection. Speculating on potential contributors to the persistence of long COVID, they highlight sustained elevation of proinflammatory cytokines, lingering viral presence, triggered autoimmunity, or concealed tissue damage beyond the reach of standard clinical tests.  As per the editorial experts have boldly proposed a hypothesis that SARS-CoV-2 might initiate fundamental alterations in the mechanisms regulating immune homeostasis, thereby influencing tissue inflammation.
Back home in India, a recent peer-reviewed study by the Indian Council of Medical Research (ICMR) sheds light on factors associated with the increased risk of sudden death among young adults in the country, following hospitalization due to COVID-19. The study, titled ‘Factors associated with unexplained sudden deaths among adults aged 18-45 years in India – a multicentric matched case-control study,’ was recently published in the Indian Journal of Medical Research.

Conducted across 47 tertiary care hospitals in India, the study aimed to explore potential contributors to sudden deaths among individuals aged 18-45 years who had no known co-morbidities and were hospitalized for COVID-19 between October 2021 and March 2023. The analysis included 729 cases and 2,916 individuals in the control group.

In fact, the study revealed that factors such as a family history of sudden deaths, binge drinking, and intense unaccustomed activity, rather than COVID-19 vaccines, were more likely to contribute to the heightened risk of sudden death. The deaths, occurring within 24 hours of hospitalization, were primarily attributed to cardiac reasons, even though they might not have resulted from a cardiac arrest.

The director of ICMR-National Institute of Epidemiology Manoj Murhekar, emphasized that COVID vaccination did not emerge as a contributing factor to sudden deaths. On the contrary, vaccination might have played a preventive role. Murhekar underscored that the primary goal of vaccination remains the prevention of severe outcomes from COVID-19. Despite documented adverse events, notably thromboembolic events, post-COVID-19 vaccination, the study suggests limited evidence supporting protection against all-cause mortality across different age groups.